Accuray: (NASD: ARAY)
$5.90
0.03 (0.51%)
Volume 489,473
Jun 18 04:00 PM ET
Zacks Rank: 4-Sell 
| #4 |
Overview Quote
Stock Activity
| Day Low - High | 5.82 - 5.91 |
| 52wk Low - High | 3.76 - 7.44 |
| Previous Close | 5.87 |
| Avg. Volume | 702,745 |
| Industry | MED INSTRUMENTS |
| Market Cap | 435.06 M |
| Div - Yield | 0.00 - 0.00 |
| Beta | 1.08 |
| P/E (F1) | 0.00 |
| Current Year Est. | -1.05 |
| Quarterly Earnings ESP |
NA |
Premium research
Zacks Rank
|
 4 |
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
178 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| P/E (F1) | NA |
| PEG Ratio | NA |
| Current Year Est. | -1.05 |
| Current Quarter Estimate | -0.17 |
| Most Accurate Estimate | NA |
| Earnings ESP |
NA |
| Next Earnings Report Date | 09-05-2013 |
| EPS Last Year | -1.10 |
| Expected Earnings Growth | 15.00% |
Company Description
ACCURAY INCORPORATED based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 40,000 patients worldwide and currently more than 130 systems have been installed in leading hospitals in the Americas, Europe and Asia.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (06/2013) |
Next Qtr (09/2013) |
Current Year (06/2013) |
Next Year (06/2014) |
|
|---|---|---|---|---|
| Average Estimate | -0.17 | -0.14 | -1.05 | -0.37 |
| Number of Estimates | 6 | 6 | 6 | 6 |
| Low Estimate | -0.27 | -0.17 | -1.18 | -0.59 |
| High Estimate | -0.01 | -0.08 | -0.82 | NA |
| Year Ago EPS | -0.20 | -0.23 | -0.81 | -1.05 |
| EPS Growth | 17.50% | 39.86% | -29.84% | 64.98% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| ACCURAY INC | ARAY | 5.87 | |
|
| NATUS MEDICAL | BABY | 14.08 | |
|
| CRYOLIFE INC | CRY | 6.08 | |
|
| DELCATH SYS INC | DCTH | 0.49 | |
|
| GLOBUS MEDICAL | GMED | 15.88 | |
|
| HEARTWARE INTL | HTWR | 92.61 | |
|
| MELA SCIENCES | MELA | 0.85 | |
|
| OXYSURE SYSTEMS | OXYS | 0.79 | |
|
| SUNSHINE HEART | SSH | 5.74 | |
|
| ABIOMED INC | ABMD | 21.74 | |
|
Sector:Medical>> Industry:MED INSTRUMENTS
COMPARE TICKER vs. Its Peers
Zacks Commentary
Akamai, Barnes Group, Varian Medical Systems, Siemens and Accuray highlighted as Zacks Bull and Bear of the Day
Jun 17, 2013
Varian Links With Siemens Systems
Jun 14, 2013
Accuray Expands in France
Jun 07, 2013
Varian Wins 510(k) for X-Ray System
May 28, 2013
Accuray Presents Positive Data
May 24, 2013
Accuray Lags 3Q Earnings Est
May 08, 2013
MYGN Earnings Easily Beat, Guidance Up
May 08, 2013
Accuray Lags 3Q Earnings Est
May 08, 2013
Financials
| EPS TTM | -1.10 |
| Sales | 409 |
| Net Income | -105 |
| Price/Earnings | NA |
| Price/Book | 3.56 |
| Price/Cash Flow | NA |
| Price/Sales | 1.31 |
News
Shares of Accuray Under Pressure, Down 1.5% - Financial News Network Online - Market Movers
Jun 14, 2013
The 5 Worst Medical Device Stocks of 2013 - TheMotleyFool
Jun 14, 2013
First U.S. Center to Treat a Patient with the new CyberKnifeA? M6(TM) System - Pr Newswire
Jun 13, 2013
Volcano has Relatively Underperformed its Peers in the Health Care Equipment Industry (VOLC, SIRO, ARAY, CFN, MR) - Financial News Network Online - News Corner
Jun 13, 2013
Relatively Good Performance Detected in Shares of Volcano in the Health Care Equipment Industry (VOLC, RMD, IDXX, DXCM, ARAY) - Financial News Network Online - News Corner
Jun 12, 2013
Best Relative Performance in the Health Care Equipment Industry Detected in Shares of Edwards Lifesciences (EW, HOLX, HRC, BSX, ARAY) - Financial News Network Online - News Corner
Jun 11, 2013
Accuray: First Patient Treated Worldwide with New TomoHDA System - Close-Up Media
Jun 10, 2013
Relatively Good Performance Detected in Shares of Accuray in the Health Care Equipment Industry (ARAY, MAKO, HOLX, DXCM, VAR) - Financial News Network Online - News Corner
Jun 10, 2013
Broker Recommendations
| Current ABR | 2.00 |
| ABR (Last Week) | 2.00 |
| # of recs in ABR | 7 |
| Average Target Price | 7.60 |
| Industry Rank by ABR | 178 out of 265 |
| Rank in Industry | 40 out of 54 |
